These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 28454409)

  • 1. NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Sorbye H; Hjortland GO; Vestermark LW; Sundlov A; Assmus J; Couvelard A; Perren A; Langer SW
    J Neuroendocrinol; 2024 Jun; ():e13428. PubMed ID: 38937137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
    Panzuto F; Partelli S; Campana D; de Braud F; Spada F; Cives M; Tafuto S; Bertuzzi A; Gelsomino F; Bergamo F; Marcucci S; Mastrangelo L; Massironi S; Appetecchia M; Filice A; Badalamenti G; Bartolomei M; Amoroso V; Landoni L; Rodriquenz MG; Valente M; Colao A; Isidori A; Fanciulli G; Bollina R; Ciola M; Butturini G; Marconcini R; Arvat E; Cinieri S; Berardi R; Baldari S; Riccardi F; Spoto C; Giuffrida D; Gattuso D; Ferone D; Rinzivillo M; Bertani E; Versari A; Zerbi A; Lamberti G; Lauricella E; Pusceddu S; Fazio N; Dell'Unto E; Marini M; Falconi M
    Endocrine; 2024 Apr; 84(1):42-47. PubMed ID: 38175391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated neuroendocrine neoplasm with undetected primary tumor.
    Ribeiro FB; Siqueira SAC; Gonçalves MC; Costa ADCL
    Autops Case Rep; 2012; 2(3):13-20. PubMed ID: 31528575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term organoid culture of a small intestinal neuroendocrine tumor.
    D'Agosto S; Fiorini E; Pezzini F; Delfino P; Simbolo M; Vicentini C; Andreani S; Capelli P; Rusev B; Lawlor RT; Bassi C; Landoni L; Pea A; Luchini C; Scarpa A; Corbo V
    Front Endocrinol (Lausanne); 2023; 14():999792. PubMed ID: 37082125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives.
    Mancarella C; Scotlandi K
    Front Cell Dev Biol; 2019; 7():363. PubMed ID: 32010687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.
    Lee L; Ito T; Jensen RT
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1029-1050. PubMed ID: 31738624
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.
    Liu J; Liu Y; Gong W; Kong X; Wang C; Wang S; Liu A
    Oncol Lett; 2019 Nov; 18(5):4744-4752. PubMed ID: 31611984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.
    Kidd M; Modlin IM; Bodei L; Drozdov I
    Cell Mol Gastroenterol Hepatol; 2015 Mar; 1(2):131-153. PubMed ID: 28210673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms.
    Er LM; Li Y; Wu ML; Zhao Q; Tan BB; Wang XL; Wang SJ
    Oncol Lett; 2017 Apr; 13(4):2391-2396. PubMed ID: 28454409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasm.
    Yang QC; Wang YH; Lin Y; Xue L; Chen YJ; Chen MH; Chen J
    Int J Clin Exp Pathol; 2014; 7(7):4204-12. PubMed ID: 25120800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 15. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
    BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.